Welcome to "NFL Thoughts," a wide-ranging, in-depth look at some of the top storylines of the 2025 season. This week, we're examining two young quarterbacks who will be inexorably tied to one another: ...
As recently as last year, Eby was still dismissing critics who said decriminalization would only make everything worse You can save this article by registering for free here. Or sign-in if you have an ...
NEW WESTMINSTER — Police in New Westminster say a woman with three outstanding warrants was arrested earlier this week after a break and enter in the city. They say officers responded to a report on ...
The Wyoming Department of Health will hold a public meeting at the University of Wyoming Thursday, Oct. 2, to gather input in developing a proposal for the federal government’s new Rural Health ...
RALEIGH — With Medicaid funding cuts scheduled to go into effect next month, Gov. Josh Stein joined affected North Carolinians to urge the N.C. General Assembly to reverse the cuts by fully funding ...
The Houston Texans are in soul-searching mode after an 0-3 start to the season, and on Tuesday they made a surprising personnel move when they released veteran safety C.J. Gardner-Johnson, per CBS ...
Cybersecurity researchers have discovered what they say is the earliest example known to date of a malware that bakes in Large Language Model (LLM) capabilities. The malware has been codenamed ...
Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily. But in an interview this week on the ...
On August 12, 2025, the Board approved a reverse stock split of the Company’s outstanding shares of Common Stock at a ratio of one-for-five (the “Reverse Stock Split”). The Reverse Stock Split is ...
Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily. When President Donald Trump announced on ...
The MarketWatch News Department was not involved in the creation of this content. CAMBRIDGE, Mass., July 24, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback